510(k) K033982
K033982 is an FDA 510(k) premarket notification submitted by Vysis for the device "MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST". The FDA issued a decision of Substantially Equivalent on January 22, 2004. The device falls under product code MMW (System, Test, Tumor Marker, Monitoring, Bladder), a Class II device regulated under 21 CFR 866.6010. Vysis has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 22, 2004
- Date Received
- December 23, 2003
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Tumor Marker, Monitoring, Bladder
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type